XOMA Corp (NASDAQ:XOMA) saw a significant increase in short interest during the month of January. As of March 31st, there was short interest totalling 9,384,397 shares, an increase of 43.2% from the March 14th total of 6,552,758 shares, AmericanBankingNews.com reports. Currently, 8.9% of the shares of the stock are sold short. XOMA Corp (NASDAQ:XOMA) shares after opening at $3.99 moved to $4.22 on last trade day and at the end of the day closed at $4.20. Company price to sales ratio in past twelve months was calculated as 12.61 and price to cash ratio as 3.68. XOMA Corp (NASDAQ:XOMA) showed a negative weekly performance of -10.06%.
Infoblox Inc (NASDAQ:BLOX) was upgraded by analysts at Zacks from an underperform rating to a neutral rating. The firm currently has $18.30 target price on the stock. Infoblox Inc (NYSE:BLOX) shares advanced 6.15% in last trading session and ended the day on $18.98. BLOX return on equity ratio is recorded as -2.90% and its return on assets is -1.70%. Infoblox Inc (NYSE:BLOX) yearly performance is -9.32%.
Repligen Corporation (NASDAQ:RGEN) will replace Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. Repligen Corporation (NASDAQ:RGEN) shares moved up 5.12% in last trading session and was closed at $14.37 while trading in range of $13.42 – $14.83 – Repligen Corporation (NASDAQ:RGEN) year to date (YTD) performance is 5.35%.
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the first quarter ended March 31, 2014 before the U.S. financial markets open on Tuesday, May 6, 2014. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) weekly performance is 4.62%. On last trading day company shares ended up $11.55. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) distance from 50 day simple moving average (SMA50) is -22.38%. Analysts mean target price for the company is $19.13.